Terms: = Head and neck cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Staging
64 results:
1. braf V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
2. How do
Mukhtar N; Alhamoudi K; Alswailem M; Alhindi H; Murugan AK; Alghamdi B; Alzahrani AS
Front Endocrinol (Lausanne); 2023; 14():1270796. PubMed ID: 37859987
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of lymph node metastasis in level IIB and contralateral level VI for papillary thyroid carcinoma with pN1b and safety of low collar extended incision for neck dissection in level II.
Ning Y; Liu Y; Zeng D; Zhou Y; Ma L; Dong S; Sheng J; Wu G; Tian W; Cai Y; Li C
World J Surg Oncol; 2023 Aug; 21(1):249. PubMed ID: 37592337
[TBL] [Abstract] [Full Text] [Related]
4. Validation of dynamic risk stratification and impact of braf in risk assessment of thyroid cancer, a nation-wide multicenter study.
Pérez-Fernández L; Sastre J; Zafón C; Oleaga A; Castelblanco E; Capel I; Galofré JC; Guadalix-Iglesias S; De la Vieja A; Riesco-Eizaguirre G
Front Endocrinol (Lausanne); 2022; 13():1071775. PubMed ID: 36714606
[TBL] [Abstract] [Full Text] [Related]
5. Mutation-based, short-term "neoadjuvant" treatment allows resectability in stage IVB and C anaplastic thyroid cancer.
Maurer E; Eilsberger F; Wächter S; Riera Knorrenschild J; Pehl A; Holzer K; Neubauer A; Luster M; Bartsch DK
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1509-1518. PubMed ID: 36637521
[TBL] [Abstract] [Full Text] [Related]
6. Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features.
Lei Y; Feng S; Yu Q; Shen G; Yuan L; Huang W
Jpn J Clin Oncol; 2022 Nov; 52(11):1311-1320. PubMed ID: 35863013
[TBL] [Abstract] [Full Text] [Related]
7. Sinonasal Mucosal Melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival.
Guo R; Jenkins SM; Johnson BJ; Reed K; Kroneman T; Choby G
Laryngoscope; 2022 Dec; 132(12):2350-2358. PubMed ID: 35661370
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract] [Full Text] [Related]
9. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
10. Neoadjuvant Cytoreductive Treatment With braf/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Blankenstein SA; Rohaan MW; Klop WMC; van der Hiel B; van de Wiel BA; Lahaye MJ; Adriaansz S; Sikorska K; van Tinteren H; Sari A; Grijpink-Ongering LG; van Houdt WJ; Wouters MWJM; Blank CU; Wilgenhof S; van Thienen JV; van Akkooi ACJ; Haanen JBAG
Ann Surg; 2021 Aug; 274(2):383-389. PubMed ID: 33843797
[TBL] [Abstract] [Full Text] [Related]
11. Differentiation of benign thyroid nodules from malignant thyroid nodules through miR-205-5p and thyroid-stimulating hormone receptor mRNA.
Zhou J; Cao L; Chen Z
Hormones (Athens); 2021 Sep; 20(3):571-580. PubMed ID: 33788150
[TBL] [Abstract] [Full Text] [Related]
12. Recent advances in the management of cutaneous malignant melanoma: our case cohort.
Sayan A; Plant R; Eccles B; Davies C; Ilankovan V
Br J Oral Maxillofac Surg; 2021 Jun; 59(5):534-545. PubMed ID: 33766481
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid cancer in Adults: From RAS/braf-like Tumor Designations to Molecular Risk Stratification.
Soares P; Póvoa AA; Melo M; Vinagre J; Máximo V; Eloy C; Cameselle-Teijeiro JM; Sobrinho-Simões M
Endocr Pathol; 2021 Mar; 32(1):44-62. PubMed ID: 33651322
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation.
Wang T; Wu Y; Zhou H; Wu C; Zhang X; Chen Y; Zhao D
BMC Gastroenterol; 2021 Jan; 21(1):38. PubMed ID: 33499821
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of
van Ipenburg JA; Naus NC; Dubbink HJ; van Ginderdeuren R; Missotten GS; Paridaens D; Verdijk RM
Br J Ophthalmol; 2021 Oct; 105(10):1454-1461. PubMed ID: 33127831
[TBL] [Abstract] [Full Text] [Related]
16. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
[TBL] [Abstract] [Full Text] [Related]
17. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.
Potter SL; Reuther J; Chandramohan R; Gandhi I; Hollingsworth F; Sayeed H; Voicu H; Kakkar N; Baksi KS; Sarabia SF; Lopez ME; Chelius DC; Athanassaki ID; Mahajan P; Venkatramani R; Quintanilla NM; Lopez-Terrada DH; Roy A; Parsons DW
Pediatr Blood Cancer; 2021 Jan; 68(1):e28741. PubMed ID: 33009870
[TBL] [Abstract] [Full Text] [Related]
18. Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid cancer.
Suh S; Goh TS; Kim YH; Oh SO; Pak K; Seok JW; Kim IJ
Endocrinol Metab (Seoul); 2020 Jun; 35(2):435-442. PubMed ID: 32615728
[TBL] [Abstract] [Full Text] [Related]
19. Challenges in sentinel node pathology in the era of adjuvant treatment.
Franke V; Madu MF; Bierman C; Klop WMC; van Houdt WJ; Wouters MWJM; van de Wiel BA; van Akkooi ACJ
J Surg Oncol; 2020 Oct; 122(5):964-972. PubMed ID: 32602119
[TBL] [Abstract] [Full Text] [Related]
20. The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
Ascierto PA; Agarwala SS; Eggermont A; Gershenwald JE; Grob JJ; Hamid O; Michielin O; Postow M; Puzanov I; Zarour HM; Caracò C; Testori A
J Transl Med; 2020 Apr; 18(1):171. PubMed ID: 32299446
[TBL] [Abstract] [Full Text] [Related]
[Next]
